The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens için istatistikler
Toplam ziyaret
| views | |
|---|---|
| The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens | 2 |
Aylık toplam ziyaret
| views | |
|---|---|
| Temmuz 2024 | 0 |
| Ağustos 2024 | 0 |
| Eylül 2024 | 2 |
| Ekim 2024 | 0 |
| Kasım 2024 | 0 |
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
